ITGB3 and breast cancer: To explore the biological function of ITGB3 and ITGAV in brain-metastatic BC cells, we established knockdown subclones of 4T1-BR5 and MDA231-BrM2 by transducing them with vectors encoding shRNA targeting ITGB3 or ITGAV.